We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$6.79B
AUM Growth
+$1.29B
Cap. Flow
+$933M
Cap. Flow %
13.74%
Top 10 Hldgs %
15.83%
Holding
1,205
New
433
Increased
209
Reduced
253
Closed
295

Top Buys

Rank Stock Value
1
LAZ icon
Lazard
LAZ
+$67.3M
2
PPG icon
PPG Industries
PPG
+$49.7M
3
AAPL icon
Apple
AAPL
+$46.8M
4
MU icon
Micron Technology
MU
+$42.1M
5
HRB icon
H&R Block
HRB
+$41.7M

Sector Composition

Rank Sector Weight
1 Industrials 12.8%
2 Communication Services 12.26%
3 Healthcare 12.21%
4 Materials 11.4%
5 Financials 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNCR
801
DELISTED
Synchronoss Technologies
SNCR
$247K ﹤0.01%
785
-471
-38% -$135K
PAC icon
802
Grupo Aeroportuario del Pacifico
PAC
$12.9B
$246K ﹤0.01%
+3,645
New +$228K
FIO
803
DELISTED
FUSION-IO INC COM
FIO
$246K ﹤0.01%
21,805
-15,127
-41% -$140K
RGS icon
804
Regis Corp
RGS
$69.9M
$244K ﹤0.01%
866
-519
-37% -$141K
AREX
805
DELISTED
Approach Resources Inc.
AREX
$244K ﹤0.01%
10,750
-6,450
-38% -$131K
QTS
806
DELISTED
QTS REALTY TRUST, INC.
QTS
$243K ﹤0.01%
8,500
-79,314
-90% -$2.19M
MANT
807
DELISTED
Mantech International Corp
MANT
$242K ﹤0.01%
8,187
-4,913
-38% -$145K
ACM icon
808
Aecom
ACM
$9.07B
$241K ﹤0.01%
7,500
-4,500
-38% -$145K
ICPT
809
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$237K ﹤0.01%
+1,000
New +$264K
FDO
810
DELISTED
FAMILY DOLLAR STORES
FDO
$236K ﹤0.01%
3,572
-362,242
-99% -$21.8M
CHDN icon
811
Churchill Downs
CHDN
$6.03B
$234K ﹤0.01%
+15,600
New +$228K
FCRD
812
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$234K ﹤0.01%
+16,700
New +$225K
ACHN
813
DELISTED
Achillion Pharmaceuticals
ACHN
$233K ﹤0.01%
+30,829
New +$123K
RDEN
814
DELISTED
ELIZABETH ARDEN INC
RDEN
$233K ﹤0.01%
+10,880
New +$313K
CMG icon
815
Chipotle Mexican Grill
CMG
$40.8B
$232K ﹤0.01%
19,600
-2,400
-11% -$26K
SKYW icon
816
Skywest
SKYW
$4.11B
$232K ﹤0.01%
19,000
-11,400
-38% -$138K
TXT icon
817
Textron
TXT
$16.6B
$232K ﹤0.01%
6,062
-3,638
-38% -$143K
AGX icon
818
Argan
AGX
$7.98B
$231K ﹤0.01%
+6,200
New +$186K
WNR
819
DELISTED
Western Refining Inc
WNR
$230K ﹤0.01%
6,125
-23,348
-79% -$941K
TXNM
820
TXNM Energy Inc
TXNM
$6.47B
$229K ﹤0.01%
+7,800
New +$218K
WINT
821
DELISTED
Windtree Therapeutics Inc
WINT
$229K ﹤0.01%
+9,180
New +$235K
TMO icon
822
Thermo Fisher Scientific
TMO
$211B
$228K ﹤0.01%
1,933
-212
-10% -$24.9K
BKH icon
823
Black Hills Corp
BKH
$5.73B
$227K ﹤0.01%
+3,700
New +$215K
DMC
824
Del Monte Corp
DMC
$1.35B
$227K ﹤0.01%
+7,400
New +$210K
CSGS
825
DELISTED
CSG Systems International
CSGS
$225K ﹤0.01%
8,625
-5,175
-38% -$135K

Similar funds

Marshall Wace's Q2 2014 Portfolio in Review

As of Q2 2014, Marshall Wace held 1,205 positions worth $6.79B, up 24% from $5.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $933M of net new capital in Q2 2014, opening 433 new positions and adding to 209 existing holdings. Its largest new stake was H&R Block: 1,400,000 shares worth $46.9M.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was SANDISK CORP, an estimated $35.8M trimmed.

  • Marshall Wace's largest Q2 2014 buy was H&R Block: 1,400,000 shares worth $46.9M.
  • Marshall Wace added most to Lazard in Q2 2014, an estimated $67.3M increase.
  • Marshall Wace's biggest Q2 2014 reduction was SANDISK CORP, cutting an estimated $35.8M.
  • Marshall Wace fully exited SANTANDER CONSUMER USA HOLDINGS INC in Q2 2014, selling an estimated $54.9M.
  • Marshall Wace's ten largest holdings make up 16% of its $6.79B portfolio in Q2 2014.
  • Marshall Wace opened 433 new positions and closed 295 in Q2 2014.
  • Marshall Wace's portfolio value rose 24% quarter-over-quarter to $6.79B.

Based on Marshall Wace's 13F filing for Q2 2014, filed 14 Aug 2014.